UniQure sells Mass­a­chu­setts man­u­fac­tur­ing site to Genezen as it con­tin­ues to down­size

UniQure is sell­ing its on­ly US man­u­fac­tur­ing site to vi­ral vec­tor CD­MO Genezen for $25 mil­lion, as the gene ther­a­py biotech con­tin­ues to trim op­er­a­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.